EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields

Jiaxuan Cheng iD, Evan M Cale, Amirabbas Maghsoudi iD, Matthew S Sutton iD, Nancy S Longo iD, Rebecca A Gillespie, Lingshu Wang, Ivan Kosik, Sue Chong iD, Atsuhiro Yasuhara, Tatsiana Bylund, Arne Schön iD and 48 more

Advanced Science · 2026-11 · 13 (61)

DOI: 10.1002/advs.77172 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-14. Written by Jiaxuan Cheng and 59 co-authors. Institution: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. Major MEDLINE topics: Polysaccharides, Antibodies, Viral. 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: Leidos Biomedical Research contracts, Frederick National Laboratory for Cancer Research, Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Viral entry glycoproteins are often shielded from immune recognition by dense N ‐linked glycans that limit antibody access to protein epitopes. While glycan‐reactive antibodies with unusual architectures have been described, how canonical Y‐shaped antibodies engage these glycan‐rich surfaces remains poorly defined. Here, we characterize two human antibodies, VRC35 and VRC36, isolated from an HIV‐1‐infected donor, that recognize diverse glycosylated viral glycoproteins. Cryo‐electron microscopy structural analyses of these antibodies in complex with viral entry glycoproteins, including HIV‐1 envelope, influenza hemagglutinin, SARS‐CoV‐2 spike, and the Lassa virus glycoprotein complex, reveal adaptive Fab stoichiometries ranging from single‐Fab binding to dimeric and higher‐order assemblies are mediated by intra‐ and inter‐IgG interactions that depend on local glycan organization. Dense glycan clustering on HIV‐1 and influenza glycoproteins supports multivalent Fab assemblies and correlates with neutralization activity, whereas sparse glycan environments on SARS‐CoV‐2 and Lassa virus favor weak or heterogeneous engagement without neutralization. Structural and mutational analyses further demonstrate that homotypic Fab–Fab interactions stabilize multivalent engagement and contribute to neutralizing activity. Together, these findings define a structural framework in which viral glycan organization constrains antibody valency and engagement, while somatic hypermutation contributes to the acquisition of homotypic Fab‐Fab interactions that facilitate multivalent recognition of viral glycan shields.

Subjects

MeSH terms (MEDLINE)

PolysaccharidesAntibodies, ViralHumansCryoelectron MicroscopySARS-CoV-2HIV-1Immunoglobulin Fab FragmentsLassa virusEpitopesSpike Glycoprotein, CoronavirusVirus Internalization

Author keywords

HIV‐1 envelopebroadly neutralizing antibodycryo‐EMglycan recognitionhomotypic assemblymultivalent bindingsomatic hypermutationviral glycan shield

Substances

PolysaccharidesAntibodies, ViralImmunoglobulin Fab FragmentsEpitopesSpike Glycoprotein, Coronavirus

Authors and institutions

  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • Department of Biochemistry and Molecular Biophysics and Zuckerman Mind Brain Behavior Institute, Columbia University, New York, New York, USA.
  • Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Drukier Institute for Children's Health, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
  • Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.

ORCID profiles: Jiaxuan Cheng, Amirabbas Maghsoudi, Matthew S Sutton, Nancy S Longo, Sue Chong, Arne Schön, Prabhanshu Tripathi, Nicholas C Morano, Allison B Lupatkin, Myungjin Lee, Cuiping Liu, David J Van Wazer, Danyi Wang, Lingyuan Wu, Michael J Ernandes, Jonah S Merriam, Li Ou, Qi Qiu, Sarah Rubin, Andrea R Shiakolas, Sanjay Srivatsan, Mark Connors, Jason G Gall, Yicheng Guo, Q Paula Lei

Funding

  • Leidos Biomedical Research contracts
  • Frederick National Laboratory for Cancer Research
  • Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health

Cite

APA

Cheng, J., Cale, E. M., Maghsoudi, A., Sutton, M. S., Longo, N. S., Gillespie, R. A., Wang, L., Kosik, I., Chong, S., Yasuhara, A., Bylund, T., Schön, A., Tripathi, P., Tsybovsky, Y., Lei, H., Morano, N. C., Lupatkin, A. B., Morton, A. J., Lang, Z. C., …, & Mascola, J. R. (2026). Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields. Advanced Science, 13(61). https://doi.org/10.1002/advs.77172

Vancouver

Cheng J, Cale EM, Maghsoudi A, Sutton MS, Longo NS, Gillespie RA, et al. Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields. Advanced Science. 2026;13(61). doi:10.1002/advs.77172

BibTeX
@article{Cheng2026,
  author = {Cheng, Jiaxuan and Cale, Evan M and Maghsoudi, Amirabbas and Sutton, Matthew S and Longo, Nancy S and Gillespie, Rebecca A and Wang, Lingshu and Kosik, Ivan and Chong, Sue and Yasuhara, Atsuhiro and Bylund, Tatsiana and Schön, Arne and Tripathi, Prabhanshu and Tsybovsky, Yaroslav and Lei, Haotian and Morano, Nicholas C and Lupatkin, Allison B and Morton, Abraham J and Lang, Zabrina C and Becker, Jordan E and Frascilla, Isabella R and Lee, Myungjin and Li, Ning and Liu, Cuiping and Roark, Ryan S and Shen, Chen-Hsiang and Teng, I-Ting and Van Wazer, David J and Wang, Danyi and Wu, Lingyuan and Ahlsen, Goran and Castro, Mike and Du, Haijuan and Ernandes, Michael J and Li, Tiansheng and Lin, Bob C and Louder, Mark K and McKee, Krisha and Merriam, Jonah S and O'Dell, Sijy and Ou, Li and Pletnev, Sergei and Prikryl, David and Qiu, Qi and Rubin, Sarah and Sastry, Mallika and Schmidt, Stephen D and Shajahan, Asif and Shiakolas, Andrea R and Srivatsan, Sanjay and Zhang, Baoshan and Zhou, Qiong and Connors, Mark and Gall, Jason G and Guo, Yicheng and Huang, Rick K and Huang, Yaoxing and Koup, Richard A and Lei, Q Paula and Mascola, John R},
  title = {Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {61},
  doi = {10.1002/advs.77172}
}
Start for free →